INS and polycystic ovary syndrome: In young, non-diabetic patients with PCOS, GLP-1 RAs have also provided beneficial effects on insulin sensitivity, thus addressing many manifestations of PCOS, as approximately 70% of women are insulin resistant and 80% are overweight or obese.